心臓T細胞リンパ腫に次ぐフルミナント心筋炎
Yifei Wang1, Huan Li2, Shanquan Gao1
1Department of Cardiology, Beijing Tsinghua Changgung Hospital, Tsinghua Medicine, Tsinghua University, Beijing, China.
JACC. Case reports
|August 22, 2025
まとめ
心臓のT細胞リンパ腫は めったに発生しない 侵襲的な癌で 急性心筋炎を引き起こします 早期の心筋生検は この状態の診断に不可欠です 特に原因不明で 急速に衰える心臓機能の場合です
科学分野:
- 腫瘍学
- 心臓病科
- 病理学について
背景:
- 心臓T細胞リンパ腫は 希少で攻撃的な悪性腫瘍です
- 早期診断を遅らせることが多いのです
- この状態は急激に進行し,重度の心臓機能障害になる可能性があります.
研究 の 目的:
- 心臓のT細胞リンパ腫が fulminant myocarditisとして報告される.
- 診断の課題と早期介入の重要性を強調する
- 心臓病の診断における 心筋組織生検の役割を強調する.
主な方法:
- 73歳の男性患者の症例研究です 昏睡,食欲低下,腹部不快感.
- 患者は高血糖症を発症し,急激に発症した心筋炎になりました.
- 診断はT細胞リンパ腫に一致するリンパ球浸透を示した心筋生検で確認された.
主要な成果:
- 患者の心臓機能は標準的な治療法にもかかわらず急速に低下した.
- 外体膜の酸素供給と 大動脈内気球ポンプのサポートが必要でした
- 心筋生検による ヒト内疾患評価により 心臓T細胞リンパ腫が確認されました
結論:
- 心臓のT細胞リンパ腫と fulminant心筋炎は極めてまれで,予後が悪い.
- 曖昧な症状による診断の遅延は一般的です.
- 早期の心筋生検は,急速に悪化する心臓機能の迅速な診断と管理に不可欠です.
関連する概念動画
Myocarditis II: Clinical Features and Diagnostic Tests
20
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
20
Myocarditis I: Introduction
28
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
28
Myocarditis III: Medical Management
15
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
15
Cardiomyopathy II: Dilated Cardiomyopathy
22
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
22
Myocarditis IV: Nursing Management
26
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
26
Cardiomyopathy I: Introduction and Classification
51
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
51


